NeuroScience / Pharmasan Labs Pays .5 Million to Settle Whistleblower Lawsuit

Baum, Hedlund, Aristei & Goldman Announces that NeuroScience / Pharmasan Labs Pays $8.5 Million to Settle Whistleblower Lawsuit  Pharmasan Labs, Inc., NeuroScience, Inc. and two executives have agreed to pay $8.5 million to settle a health care fraud whistleblower lawsuit claiming both companies violated the False Claims Act by improperly billing for laboratory tests not eligible for reimbursement under Medicare Part B and tests that were submitted by non-approved, non-physician practitioners. The Relator (whistleblower) Richard Forrest, a former billing manager at Pharmasan, will receive a reward of $1.13 million for bringing the fraud allegations to the government’s attention. He was represented in this case by Baum, Hedlund, Aristei & Goldman attorneys Mark H. Schlein and Diane Marger Moore. Pharmasan is a clinical laboratory that provides various neurology, endocrinology, and immunology…


Link to Full Article: NeuroScience / Pharmasan Labs Pays .5 Million to Settle Whistleblower Lawsuit